These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21873315)
1. Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. Sommer JR; Estrada JL; Collins EB; Bedell M; Alexander CA; Yang Z; Hughes G; Mir B; Gilger BC; Grob S; Wei X; Piedrahita JA; Shaw PX; Petters RM; Zhang K Br J Ophthalmol; 2011 Dec; 95(12):1749-54. PubMed ID: 21873315 [TBL] [Abstract][Full Text] [Related]
2. Long-term retinal cone survival and delayed alteration of the cone mosaic in a transgenic mouse model of stargardt-like dystrophy (STGD3). Kuny S; Filion MA; Suh M; Gaillard F; Sauvé Y Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):424-39. PubMed ID: 24334447 [TBL] [Abstract][Full Text] [Related]
3. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks. Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735 [TBL] [Abstract][Full Text] [Related]
4. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284 [TBL] [Abstract][Full Text] [Related]
5. Early Onset Ultrastructural and Functional Defects in RPE and Photoreceptors of a Stargardt-Like Macular Dystrophy (STGD3) Transgenic Mouse Model. Kuny S; Cho WJ; Dimopoulos IS; Sauvé Y Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7109-21. PubMed ID: 26529045 [TBL] [Abstract][Full Text] [Related]
6. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration. Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632 [TBL] [Abstract][Full Text] [Related]
7. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Zhang K; Kniazeva M; Han M; Li W; Yu Z; Yang Z; Li Y; Metzker ML; Allikmets R; Zack DJ; Kakuk LE; Lagali PS; Wong PW; MacDonald IM; Sieving PA; Figueroa DJ; Austin CP; Gould RJ; Ayyagari R; Petrukhin K Nat Genet; 2001 Jan; 27(1):89-93. PubMed ID: 11138005 [TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease. Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435 [TBL] [Abstract][Full Text] [Related]
9. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes. Vasireddy V; Vijayasarathy C; Huang J; Wang XF; Jablonski MM; Petty HR; Sieving PA; Ayyagari R Mol Vis; 2005 Aug; 11():665-76. PubMed ID: 16163264 [TBL] [Abstract][Full Text] [Related]
10. A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family. Edwards AO; Donoso LA; Ritter R Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2652-63. PubMed ID: 11581213 [TBL] [Abstract][Full Text] [Related]
11. DHA does not protect ELOVL4 transgenic mice from retinal degeneration. Li F; Marchette LD; Brush RS; Elliott MH; Le YZ; Henry KA; Anderson AG; Zhao C; Sun X; Zhang K; Anderson RE Mol Vis; 2009 Jun; 15():1185-93. PubMed ID: 19536303 [TBL] [Abstract][Full Text] [Related]
12. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. McMahon A; Butovich IA; Mata NL; Klein M; Ritter R; Richardson J; Birch DG; Edwards AO; Kedzierski W Mol Vis; 2007 Feb; 13():258-72. PubMed ID: 17356513 [TBL] [Abstract][Full Text] [Related]
13. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice. Li W; Chen Y; Cameron DJ; Wang C; Karan G; Yang Z; Zhao Y; Pearson E; Chen H; Deng C; Howes K; Zhang K Vision Res; 2007 Mar; 47(5):714-22. PubMed ID: 17254625 [TBL] [Abstract][Full Text] [Related]
14. Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration. Vasireddy V; Jablonski MM; Mandal MN; Raz-Prag D; Wang XF; Nizol L; Iannaccone A; Musch DC; Bush RA; Salem N; Sieving PA; Ayyagari R Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4558-68. PubMed ID: 17003453 [TBL] [Abstract][Full Text] [Related]
15. Differential gene expression in eyecup and retina of a mouse model of Stargardt-like macular dystrophy (STGD3). Kuny S; Gaillard F; Sauvé Y Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):664-75. PubMed ID: 22199241 [TBL] [Abstract][Full Text] [Related]
16. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Bernstein PS; Tammur J; Singh N; Hutchinson A; Dixon M; Pappas CM; Zabriskie NA; Zhang K; Petrukhin K; Leppert M; Allikmets R Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3331-6. PubMed ID: 11726641 [TBL] [Abstract][Full Text] [Related]
17. Genetics and molecular pathology of Stargardt-like macular degeneration. Vasireddy V; Wong P; Ayyagari R Prog Retin Eye Res; 2010 May; 29(3):191-207. PubMed ID: 20096366 [TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy. Maugeri A; Meire F; Hoyng CB; Vink C; Van Regemorter N; Karan G; Yang Z; Cremers FP; Zhang K Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4263-7. PubMed ID: 15557430 [TBL] [Abstract][Full Text] [Related]
19. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors. Bennett LD; Brush RS; Chan M; Lydic TA; Reese K; Reid GE; Busik JV; Elliott MH; Anderson RE Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3150-7. PubMed ID: 24722693 [TBL] [Abstract][Full Text] [Related]
20. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse. Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]